scispace - formally typeset
Search or ask a question

Showing papers on "Docosenoic Acid published in 1979"


Journal Article
TL;DR: The mean-term physiological effects of brassidic acid and erucic acid have been compared to those of their C 18 homologues, elaidic and oleic acid, in a 2(3) factorial experiment and the effects of these dietary fatty acids on the lipid contents and fatty acid compositions of different organs will be reported in a second paper.
Abstract: The mean-term physiological effects of brassidic acid (n-9, trans docosenoic acid) and of erucic acid (n-9, cis docosenoic acid) have been compared to those of their C 18 homologues, elaidic and oleic acid, in a 2(3) factorial experiment; the 3 tested factors are: 1) the chain length of the dietary monoenes (C 22:1 vs. C 18:1), 2) the geometrical configuration of their double bond (trans vs. cis) and 3) the dietary level of linoleic acid (30% vs. 1,7% of dietary fatty acids). Wistar weanling rats have been fed for 16 weeks semi-synthetic diets containing 15% of lipids by weight, in which the fatty acids under study (brassidic, erucic elaidic) ranged to 40%. Although caution has been taken to optimize the digestibility of brassidic acid (interesterification of the lipid mixture, reduced level of calcium in the diet, addition of monoglycerides), it remains lower that of erucic acid. However, because of different levels of food consumption, the absorbed amounts of the two isomers are about the same. With a high dietary supply of linoleic acid, the dietary monoenes (C 22:1 or C 18:1), cis or trans) do not induce great changes in the weight gain of the rats, when adjusted to food consumption; linoleic acid subdeficiency lowers this adjusted weight gain, except when the diet contains oleic acid as the only monoene. These effects do not parallel those observed on the absolute growth of the rats. The trans monoenes, and to a lesser extent, erucic acid, induce an increase of liver weight (adjusted to body weight). The light microscopic histological study of the heart does not reveal any difference between the brassidic acid fed-rats and those fed the C 18:1 monoenes (elaidic, oleic). In contrast, erucic acid induces definite lesions of the myocardium. The dietary level of linoleic acid has little influence on the incidence and the severity of the lesions. The effects of these dietary fatty acids on the lipid contents and fatty acid compositions of different organs will be reported in a second paper.

3 citations


Journal ArticleDOI
TL;DR: The results indicate that the susceptibility of the rat myocardium to docosenoic acids may not be as broadly relevant in other species such as the seal, pig and man as has been proposed.
Abstract: Hearts were collected from 46 harp or grey seals of various ages and sexes After fixation in formalin, sections were cut and stained with hematoxylin-eosin, and in a limited number of cases with Oil-Red-0 Histopathological examination revealed the presence of non-specific myocarditis in two instances only and no lipid deposits The percentage of docosenoic acid (primarily 22:1ω11) in blubber and heart muscle triglyceride, tabulated for grey seal dam-pup pairs is evidence of exposure from birth These results indicate that the susceptibility of the rat myocardium to docosenoic acids may not be as broadly relevant in other species such as the seal, pig and man as has been proposed

2 citations


Journal Article
TL;DR: Dietary trans monoenes (brassidic and elaidic acids) induce, as compared to their cis isomers, slight but visible changes in the profile of (n-9) polyunsaturated fatty acids in organ lipids, related to the fact that brassidic acid does not seem to have the heart pathogenic potency of erucic acid.
Abstract: The mean term effects (16 weeks) of brassidic acid (n-9 trans docosenoic acid) and erucic acid (n-9, cis docosenoic acid) on the lipids and fatty acids of different organs in the rat (plasma, adipose tissue, liver, heart) and compared to those of their C 18 homologues, elaidic and oleic acid, in a 2(3) factorial experiment; the three tested factors are: 1) the chain length of the dietary monoenes (C 22:1 vs. C 18:1), 2) the geometrical configuration of their double bond (trans vs. cis) and 3) the dietary levels (30% vs. 1,7% of dietary fatty acids). Experimental details have been reported previously [Astorg and Levillain, 1979]. With a low supply of linoleic acid, brassidic acid, brassidic acid induces a large increase of plasma triacylglycerols (TG), but this can be caused by a slow fat absorption. However, the plasma contents of cis and trans docosenoic acids do not differ greatly. Both docosenoic acids incorporate more into the lipids of heart and adipose tissue than into liver lipids, and, for each organ, more into TG than into phospholipids (PL). In heart and adipose tissue lipids, the percentage of brassidic acid is lower than that of erucic acid. In these 2 organs and in the liver, linoleic acid subdeficiency decreases the incorporation of both C 22:1 isomers into the lipids. Dietary brassidic acid is readily converted to other trans monoenes, mainly elaidic acid, which incorporates into organ lipids. The extent of this chain-shortening may be greater than that of erucic acid (to oleic acid), and this would explain the lower level of brassidic acid found in organ lipids. Last, dietary trans monoenes (brassidic and elaidic acids) induce, as compared to their cis isomers, slight but visible changes in the profile of (n-9) polyunsaturated fatty acids in organ lipids. These results are discussed and related to the fact that brassidic acid does not seem to have the heart pathogenic potency of erucic acid [see part 1 of this paper, Astorg and Levillain, 1979].

1 citations